Abstract:It is generally agreed that the liver is a key organ in the maintenance of cholesterol homeostasis. Although species variations do exist (1), there is no question that the liver makes a very significant contribution to whole body cholesterol synthesis (2). Indeed, recent studies in the rat suggest that the liver may be responsible for the synthesis of greater than 80% of newly synthesized cholesterol in the body (3). It is also well established that the liver is a major site of uptake of cholesterol from lipoprotein particles (1). The acquisition of cholesterol from lipoprotein particles is a process which occurs via both receptor-independent and receptor-dependent pathways (1). The latter pathway is considered to be more important not only from a quantitative standpoint (1) but also because of the fact that the activity of certain receptors is regulated by the hepatic demand for cholesterol (4). These observations, combined with the fact that the liver is the major site (if not the only site) of synthesis of bile acid, the chief catabolic product of cholesterol (5), suggest that the key hepatic enzymes involved in cholesterol metabolism must be very carefully regulated in order to maintain cholesterol homeostasis. Hepatic cholesterol 7α-hydroxylase (CH-7A, EC 1.14.13.7) and β-hydroxy-β-methyl-glutaryl coenzyme A reductase (HMGCoA reductase, EC 1.1.1.34) are the two key enzymes of cholesterol metabolism in the liver (2, 6). HMGCoA reductase is the rate-limiting enzyme in the biosynthesis of cholesterol (2), while CH-7A is considered to be the rate-limiting enzyme in the biosynthesis of bile acids from cholesterol (6). Since cholesterol is the precursor for bile acid biosynthesis, changes in the rate of synthesis of bile acids, in general, affect the rate of biosynthesis of cholesterol (6). Thus, the two enzymes are regulated in a coordinated manner (6).

Mechanisms of Negative Feedback Regulation of Cholesterol Biosynthesis

Sterol regulatory element binding proteins and lipid metabolism

Impaired regulation of sterol regulatory element binding protein 2 in cholesterol gallstone-susceptible mice.

N-SREBP2 Provides a Mechanism for Dynamic Control of Cellular Cholesterol Homeostasis

MMAB promotes negative feedback control of cholesterol homeostasis

Mechanisms of cholesterol and sterol regulatory element binding protein regulation of the sterol 12α-hydroxylase gene (CYP8B1)☆

Regulation of Cholesterol Homeostasis in Health and Diseases: from Mechanisms to Targeted Therapeutics

The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors

Feeding-Induced Regulation of Cholesterol Metabolism: A Unified Proposal

Research Progress of Mechanism of Action of Proteins in Cholesterol Metabolism of Sterol Regulatory Element Binding

Recent developments in the regulation of cholesterol transport by natural molecules

Mechanisms of cholesterol and sterol regulatory element binding protein regulation of the sterol 12alpha-hydroxylase gene (CYP8B1).

Pathways and Mechanisms of Cellular Cholesterol Efflux—Insight From Imaging

A basic model for cell cholesterol homeostasis

Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6

Fine‐Tuning of Cholesterol Homeostasis Controls Erythroid Differentiation

Regulation of fatty acid and cholesterol synthesis: co-operation or competition?

A key mammalian cholesterol synthesis enzyme, squalene monooxygenase, is allosterically stabilized by its substrate

Exploring Phytochemical Mechanisms in the Prevention of Cholesterol Dysregulation: A Review

Regulation of Bile Acid Biosynthesis by Hepatocyte Nuclear Factor 4Α

Sterol-responsive Element-binding Protein (SREBP) 2 Down-regulates ATP-binding Cassette Transporter A1 in Vascular Endothelial Cells: A NOVEL ROLE OF SREBP IN REGULATING CHOLESTEROL METABOLISM